Long-Term Safety of Latanoprostene Bunod Ophthalmic Solution 0.024% in Japanese Subjects With OAG or OHT
- First Posted Date
- 2013-07-11
- Last Posted Date
- 2018-07-26
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 130
- Registration Number
- NCT01895972
- Locations
- 🇺🇸
Bausch & Lomb Incorporated, Bridgewater, New Jersey, United States
Efficacy of Latanoprostene Bunod in Lowering Intraocular Pressure in Japanese Healthy Male Volunteers
- First Posted Date
- 2013-07-11
- Last Posted Date
- 2018-05-15
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 24
- Registration Number
- NCT01895985
- Locations
- 🇺🇸
Bausch & Lomb Incorporated, Madison, New Jersey, United States
A Study to Evaluate the Product Performance of a New Silicone Hydrogel Contact Lens
Not Applicable
Completed
- Conditions
- Myopia
- Interventions
- Device: Silicone Hydrogel Contact Lens
- First Posted Date
- 2013-06-10
- Last Posted Date
- 2019-07-24
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 400
- Registration Number
- NCT01873846
- Locations
- 🇺🇸
Bausch & Lomb Incorporated, Madison, New Jersey, United States
Hydrophobic Acrylic Toric IOL Designed to Reduce the Effects of Preoperative Corneal Astigmatism
Not Applicable
Completed
- Conditions
- Astigmatism
- Interventions
- Device: enVista control lensDevice: enVista® One-Piece Hydrophobic Acrylic Toric IOL
- First Posted Date
- 2013-05-13
- Last Posted Date
- 2020-09-16
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 191
- Registration Number
- NCT01852084
- Locations
- 🇺🇸
Bausch & Lomb, Irvine, California, United States
Lotemax® Gel 0.5% and Restasis 0.05% in Participants With Mild or Moderate Keratoconjunctivitis Sicca (Dry Eye Disease)
Phase 2
Completed
- Conditions
- Keratoconjunctivitis Sicca
- Interventions
- First Posted Date
- 2013-03-25
- Last Posted Date
- 2019-08-30
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 102
- Registration Number
- NCT01817582
- Locations
- 🇺🇸
Bausch & Lomb Incorporated, Irvine, California, United States
A Study to Evaluate the Performance and Safety of Artelac Rebalance® Versus Vismed in the Management of Dry Eye
Not Applicable
Withdrawn
- Conditions
- Dry Eye
- Interventions
- Device: Artelac RebalanceDevice: Vismed
- First Posted Date
- 2013-02-15
- Last Posted Date
- 2013-10-11
- Lead Sponsor
- Bausch & Lomb Incorporated
- Registration Number
- NCT01791426
Bepotastine Besilate Nasal Sprays in the Treatment of Seasonal Allergic Rhinitis (SAR)
Phase 2
Completed
- Conditions
- Seasonal Allergic Rhinitis
- Interventions
- Drug: Placebo
- First Posted Date
- 2012-12-20
- Last Posted Date
- 2020-10-05
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 617
- Registration Number
- NCT01753739
- Locations
- 🇺🇸
Bausch & Lomb Incorporated, Irvine, California, United States
Comparing Safety and Efficacy of BOL-303259-X With Timolol Maleate in Subjects With Open-Angle Glaucoma or Ocular Hypertension
Phase 3
Completed
- Conditions
- Open-Angle GlaucomaOcular Hypertension
- Interventions
- First Posted Date
- 2012-12-17
- Last Posted Date
- 2018-11-07
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 420
- Registration Number
- NCT01749904
- Locations
- 🇺🇸
Bausch & Lomb Inc., Rochester, New York, United States
Comparing the Safety and Efficacy of BOL-303259-X Ophthalmic Solution With Timolol Maleate Ophthalmic Solution in Subjects With Open-Angle Glaucoma or Ocular Hypertension
Phase 3
Completed
- Conditions
- Open-Angle GlaucomaOcular Hypertension
- Interventions
- First Posted Date
- 2012-12-17
- Last Posted Date
- 2018-11-21
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 420
- Registration Number
- NCT01749930
- Locations
- 🇺🇸
Bausch & Lomb Inc., Rochester, New York, United States
Clinical and Microbial Efficacy of Besifloxacin Ophthalmic Suspension, 0.6% in the Treatment of Bacterial Conjunctivitis
- First Posted Date
- 2012-12-04
- Last Posted Date
- 2014-10-01
- Lead Sponsor
- Bausch & Lomb Incorporated
- Target Recruit Count
- 136
- Registration Number
- NCT01740388
- Locations
- 🇺🇸
Bausch & Lomb Incorporated, Rochester, New York, United States
© Copyright 2025. All Rights Reserved by MedPath